Sierra Oncology

+$1.50 (+6.00%) Today
-$0.12 (-0.45%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRRA and other ETFs, options, and stocks.

About SRRA

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology.

CEO
Stephen George Dilly
Employees
69
Headquarters
Vancouver, British Columbia
Founded
2003

SRRA Key Statistics

Market cap
398.81M
Price-Earnings ratio
—
Dividend yield
—
Average volume
5.88M
High today
$27.44
Low today
$24.75
Open price
$25.61
Volume
1.90M
52 Week high
$29.48
52 Week low
$13.68

SRRA News

Simply Wall StJan 25

What Kind Of Investors Own Most Of Sierra Oncology, Inc.?

A look at the shareholders of Sierra Oncology, Inc. (NASDAQ:SRRA) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller
MarketWatchJan 25

Sierra Oncology Gets Loan to Support Myelofibrosis Drug Potential Rollout Following Positive Results

By Kimberly Chin Sierra Oncology Inc. said it has secured a term loan with Oxford Finance LLC that will mostly support the commercial preparation and potential
ReutersJan 25

Sierra Oncology's bone marrow cancer drug meets study main goal

Jan 25 (Reuters) - Sierra Oncology Inc (SRRA.O) said on Tuesday its experimental drug for anemic patients with a type of bone marrow cancer met the main goal of

SRRA Earnings

-$1.86
-$1.24
-$0.62
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure